Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (11): 1108-1111.DOI: 10.3969/j.issn.1673-8640.2020.11.006
Previous Articles Next Articles
Received:
2020-09-05
Online:
2020-11-30
Published:
2020-12-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.11.006
结晶类型 | 结晶名称 | 尿酸碱度 |
---|---|---|
生理性结晶 | 尿酸结晶 | 酸、中 |
草酸钙结晶 | 酸、中 | |
马尿酸结晶 | 酸 | |
磷酸钙结晶 | 中、碱 | |
磷酸氨镁结晶 | 中、碱 | |
碳酸钙结晶 | 中、碱 | |
尿酸铵结晶 | 中、碱 | |
硫酸钙结晶 | 酸 | |
非晶形尿酸盐 | 酸 | |
非晶形磷酸盐 | 中、碱 | |
病理性结晶 | 胆红素结晶 | 酸 |
胆固醇结晶 | 酸、中 | |
胱氨酸结晶 | 酸 | |
亮氨酸结晶 | 酸 | |
酪氨酸结晶 | 酸 | |
磺胺结晶 | 酸 | |
药物结晶 | 茚地那韦结晶 | 酸 |
青霉素结晶 | 酸 | |
阿昔洛韦结晶 | 酸 | |
2,8-二羟基腺嘌呤结晶 | 酸 |
结晶类型 | 结晶名称 | 尿酸碱度 |
---|---|---|
生理性结晶 | 尿酸结晶 | 酸、中 |
草酸钙结晶 | 酸、中 | |
马尿酸结晶 | 酸 | |
磷酸钙结晶 | 中、碱 | |
磷酸氨镁结晶 | 中、碱 | |
碳酸钙结晶 | 中、碱 | |
尿酸铵结晶 | 中、碱 | |
硫酸钙结晶 | 酸 | |
非晶形尿酸盐 | 酸 | |
非晶形磷酸盐 | 中、碱 | |
病理性结晶 | 胆红素结晶 | 酸 |
胆固醇结晶 | 酸、中 | |
胱氨酸结晶 | 酸 | |
亮氨酸结晶 | 酸 | |
酪氨酸结晶 | 酸 | |
磺胺结晶 | 酸 | |
药物结晶 | 茚地那韦结晶 | 酸 |
青霉素结晶 | 酸 | |
阿昔洛韦结晶 | 酸 | |
2,8-二羟基腺嘌呤结晶 | 酸 |
[1] | STRASINGER S K,LORENZO M S D. Urinalysis and body fluids[M]. 5th. Philadelphia:Davis Company,2008. |
[2] | CLARK B,BAQDUNER M W,KUNKEL G M.Diet-induced oxalate nephropathy[J]. BMJ Case Rep,2019,12(9):e231284. |
[3] | 张时民,付亮. 尿液中发现阿莫西林药物结晶3例报道及文献复习[J]. 检验医学,2019,34(10):957-959. |
[4] | 张时民. 实用尿液有形成分分析技术[M]. 2版. 北京:人民卫生出版社,2020. |
[5] | 丛玉隆. 尿液沉渣检查标准化的建议[J]. 中华检验医学杂志,2002,25(4):249-250. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||